Richard Roth, DO
Ophthalmology · Kingston, PANPI 1366449977
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,193 of the $9,317 with a category attached, or 77.2%. 16 manufacturers reported payments, led by Alcon at 39.4% of the total. Reporting peaked in 2019 at $2,522 and has fallen 64.2% since, to $903 in 2025.
Across 124 payments — averaging $75.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$4K
- Merz North America, Inc.$2K
- Rxsight Inc$2K
- AbbVie$427
- Carl Zeiss Meditec USA, Inc.$320
- Tarsus Pharmaceuticals, Inc.$115
- plus $476 from 10 others
Across 2 payments — averaging $2687.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$5K
What the payments were for
- Speaking & faculty fees$260%
- Travel & lodging$5796%
- Food & beverage$7,19377%
- Education$1,50016%
- Gifts$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 57 | $3,669 |
| Merz North America, Inc. | 24 | $2,406 |
| Rxsight Inc | 7 | $1,905 |
| AbbVie(2 entities) | 11 | $427 |
| Carl Zeiss Meditec USA, Inc. | 3 | $320 |
| Tarsus Pharmaceuticals, Inc. | 5 | $115 |
| Biotissue Holdings Inc. | 2 | $107 |
| Carl Zeiss Meditec, Inc. | 2 | $91 |
| Ocular Therapeutix, Inc. | 4 | $75 |
| NEW World Medical,inc. | 2 | $65 |
| Rayner Intraocular Lenses Limited | 2 | $45 |
| Revance Therapeutics, Inc. | 1 | $24 |
| Amgen | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Omeros Corporation | 1 | $19 |
| Aerie Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RXSIGHT CONTACT LENS$1,856
- RXSIGHT INJECTOR HANDPIECE$1,856
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$1,856
- RXSIGHT INJECTOR CARTRIDGE$1,856
- LIGHT ADJUSTABLE LENS (LAL)$1,728
- XEOMIN$1,698
- ASCLERA$852
- Clareon$548
- AcrySof IQ PanOptix UV IOL$535
- AcrySof$443
- VisuMax$295
- ORA System VerifEye$137
- ReSTOR$132
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$128
- DURYSTA$125
- PanOptix$123
- BOTOX COSMETIC$108
- AcrySof IQ PanOptix$102
How this compares
$9,317 in reported general payments places this provider in the 85th percentile of 920 ophthalmology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 53 | $1,758 |
| ErythromycinErythromycin Base | 164 | $1,715 |
| Cephalexin | 37 | $736 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 47 | $448 |
| Timolol Maleate | 26 | $272 |
| MoxifloxacinMoxifloxacin Hcl | 17 | $268 |
| Latanoprost | 17 | $230 |
| Alprazolam | 39 | $44 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Kingston
- Julia HallerPhiladelphia$1.5M
- Francis MahPittsburgh$1.1M
- Brandon AyresBala Cynwyd$929K
- David AlmeidaErie$734K
- Carl RegilloPlymouth Meeting$721K
- Robert NoeckerPittsburgh$632K
- Beeran MeghparaPhiladelphia$496K
- Michael KlufasPlymouth Meeting$393K
- Jonathan MyersPhiladelphia$359K
- Mark BlecherPhiladelphia$357K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.